Infant, Low Birth Weight

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Eagle Pharmaceuticals
Eagle PharmaceuticalsNJ - Woodcliff Lake
1 program
Liquefied petroleum gasN/A1 trial
Active Trials
NCT02944682CompletedEst. Jun 2025
Roche
RocheSTAVANGER NORWAY, Norway
1 program
epoetin betaN/A1 trial
Active Trials
NCT00593801Completed219Est. Jun 1999

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Eagle PharmaceuticalsLiquefied petroleum gas
Rocheepoetin beta

Clinical Trials (2)

Total enrollment: 219 patients across 2 trials

NCT02944682Eagle PharmaceuticalsLiquefied petroleum gas

Household Air Pollution and Health: A Multi-country LPG Intervention Trial

Start: Sep 2017Est. completion: Jun 2025
N/ACompleted
NCT00593801Rocheepoetin beta

Erythropoietin Treatment in Extremely Low Birth Weight Infants

Start: May 1998Est. completion: Jun 1999219 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space